Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ag85A is a major secretory protein and mycolyltransferase enzyme produced by *Mycobacterium tuberculosis*. It is part of the antigen 85 complex and plays critical roles in cell wall biosynthesis, host-pathogen interactions, and bacterial persistence. Ag85A elicits strong T-cell mediated immune responses, making it an attractive candidate for TB vaccine development.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis Antigen Ag85A (Ag85A).